Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-09-13 | Sold | €1.29 | — |
| 2026-09-12 | Sold | €1.29 | — |
| 2026-09-12 | List | €1.00 | — |
| 2026-09-11 | Sold | €1.29 | — |
| 2026-09-10 | Sold | €1.29 | — |
| 2026-09-10 | List | €1.00 | — |
| 2026-09-09 | List | €1.00 | — |
| 2026-09-08 | Sold | €1.29 | — |
| 2026-09-08 | List | €1.00 | — |
| 2026-09-07 | List | €1.00 | — |
| 2026-09-06 | Sold | €1.29 | — |
| 2026-09-06 | List | €1.00 | — |
| 2026-09-05 | Sold | €1.29 | — |
| 2026-09-05 | List | €1.00 | — |
Facing a New Trial / #003
Germany: lowestChoose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €1.29 | €1.00 | €1.50 | 0.0% | >5 | |
NMRAW | €1.00 | €1.00 | €1.00 | 0.0% | >5 |
Explore Victreebel (sm2+ 003) Facing a New Trial JP #003, Normal from Facing a New Trial, with 106 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.